中药药对治疗乳腺增生的机制与应用研究进展
本文系统综述了八种经典中药药对治疗乳腺增生(HMG)的药理机制与临床应用。通过整合网络药理学、分子生物学、临床前实验与临床证据,发现药对经激素调节、抗炎、增殖凋亡平衡及抗氧化应激四条通路发挥联合调控作用。临床有效率达70%-85%,副作用少于他莫昔芬。
要点
- 八种经典中药药对通过调节雌激素/孕激素信号、抑制NF-κB/IL-6/TNF-α、调控PI3K/Akt/MAPK及增强SOD/GSH-Px活性治疗HMG。
- 临床前研究显示药对以剂量依赖方式抑制乳腺细胞增殖,临床可缓解乳房疼痛并缩小肿块。
- 临床有效率70%-85%,副作用少于他莫昔芬。
核心结论
- 八种经典中药药对通过四条核心通路联合调控乳腺增生,临床有效率达70%-85%且副作用少于他莫昔芬。
研究设计与样本
- 系统综述检索PubMed(英文)与CNKI(中文)2010年1月至2025年8月的文献。
- 纳入设计明确(动物模型、体外实验、临床病例系列)且聚焦中药药对药理机制或临床应用的同行评议研究。
主要发现
- 药对通过调节雌激素/孕激素信号发挥激素调节作用。
- 药对通过抑制NF-κB、IL-6、TNF-α发挥抗炎作用。
- 药对通过PI3K/Akt、MAPK及Bcl-2/Bax通路恢复增殖-凋亡平衡。
- 药对通过增强SOD/GSH-Px活性缓解氧化应激。
- 临床前研究显示药对以剂量依赖方式抑制乳腺细胞增殖。
关键数值与推荐
- 临床研究显示药对缓解乳房疼痛、缩小肿块,有效率达70%-85%,副作用少于他莫昔芬。
临床怎么用
- 中药药对可作为乳腺增生的有效治疗选择,兼具多通路调控与较低副作用优势。
局限性
- 现有证据多来自临床前实验与病例系列,需多中心随机对照试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyperplasia of Mammary gland (HMG), a common gynecological disorder with potential malignant transformation risk, has been effectively treated using Traditional Chinese Medicine (TCM) herbal pairs. This systematic review explores the therapeutic effects and underlying mechanisms of eight classic Traditional Chinese Medicine (TCM) herbal pairs in treating hyperplasia of mammary glands (HMG). A systematic literature search was performed in PubMed (English) and CNKI (Chinese) from January 2010 to August 2025; peer-reviewed studies with clear designs (e.g., animal models, in vitro experiments, clinical case series) focusing on herbal pairs' pharmacological mechanisms or clinical applications in the treatment of HMG were included. By integrating network pharmacology, molecular biology, preclinical experiments, and clinical evidence, we found that these herbal pairs exert combined regulatory effects through four core pathways: specifically, 1. hormonal regulation by modulating estrogen/progesterone signaling; 2. anti-inflammation by suppressing NF-κB, IL-6, and TNF-α; 3. restoring proliferation-apoptosis balance via PI3K/Akt, MAPK, and Bcl-2/Bax; 4. alleviating oxidative stress by enhancing SOD/GSH-Px activities. Preclinically, they inhibit mammary cell proliferation in a dose-dependent manner; clinically, they alleviate breast pain and reduce breast lumps with an efficacy rate of 70%-85% and fewer side effects than tamoxifen. These findings validate the scientific basis of TCM herbal pair compatibility and support future translational research (e.g., multi-center randomized controlled trials).
引用
- Liu L, Zhang Y, Shen W, et al. Research progress on mechanisms and applications of Chinese herbal pairs in treating hyperplasia of mammary gland. Front Pharmacol. 2026. PMID: 41756114. doi:10.3389/fphar.2025.1704606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。